SBI Mutual Fund has significantly increased its stake in privi speciality chemicals through a substantial market acquisition, crossing the regulatory threshold that requires mandatory disclosure under SEBI regulations. The acquisition demonstrates institutional confidence in the specialty chemicals manufacturer.

Acquisition Details

On December 31, 2025, SBI Mutual Fund under its various schemes acquired 22.40 lakh shares of Privi Speciality Chemicals Limited through market purchases. This acquisition increased the fund's total shareholding from 14.23 lakh shares to 36.63 lakh shares, representing a significant jump in ownership percentage.

Regulatory Compliance

The acquisition triggered reporting requirements under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, as the fund's holding crossed the 5% threshold. SBI Funds Management Limited, through Chief Compliance Officer & Company Secretary Vinaya Datar, filed the mandatory disclosure on January 01, 2026.

The disclosure was submitted to Privi Speciality Chemicals' Company Secretary & Compliance Officer Ms. Ashwini Saumil Shah, along with copies to both the National Stock Exchange of India Limited and BSE Limited, where the company's shares are listed.

Company Share Capital Structure

Privi Speciality Chemicals maintains a stable share capital structure with no changes resulting from this transaction. The company's equity share capital remains at ₹39.06 crores, consisting of 3.91 crore equity shares with a face value of ₹10.00 each.

Transaction Characteristics

The acquisition was executed entirely through market purchases of equity shares, with no involvement of warrants, convertible securities, or other instruments. SBI Mutual Fund confirmed that it does not belong to the promoter or promoter group of Privi Speciality Chemicals, maintaining its status as an institutional investor.

The substantial acquisition reflects institutional interest in the specialty chemicals sector, with SBI Mutual Fund now holding a significant minority stake in the company. The fund's increased position establishes it as a notable shareholder in Privi Speciality Chemicals' ownership structure.

Privi Speciality Chemicals shares declined as much as 13.00% following the execution of a major block deal worth ₹1,086.00 crores. The transaction involved 38.80 lakh shares, representing 9.93% of the company's outstanding equity, executed at an average price of ₹2,799.00 per share.

Block Deal Execution and Market Impact

The completed transaction exceeded the initially announced deal parameters, demonstrating significant institutional participation:

The execution price of ₹2,799.00 per share came below the initially indicated price range of ₹2,835.00 to ₹2,850.00, representing an 11.10% discount to the previous day's closing price.

Transaction Scale Evolution

The actual block deal significantly exceeded initial projections:

The substantial increase in transaction size from ₹700.00 crores to ₹1,086.00 crores indicates expanded divestment by the promoter entity.

Shareholding Structure

The company maintains a concentrated ownership structure with strong promoter presence:

Promoters held 69.89% stake as of the September quarter, with over 26,000 retail shareholders holding up to ₹2.00 lakh authorized share capital maintaining an 8.70% stake.

Performance Context

Despite the current decline, the stock maintains strong annual performance:

The stock has gained 65.00% in the current calendar year, marking its best performance since 2021 when it recorded gains of over 240.00%.